Press Releases

Headlands Research Announces Fifth Research Site under Partnership with Pfizer to Improve Diversity in Clinical Trials

Headlands Research, a leading multinational network of clinical trial sites, today announced a fifth site, Headlands Research Orlando, as part of its partnership with Pfizer to create multiple clinical trial sites in areas with highly diverse demographics. Headlands Research Orlando satisfies the organizations’ commitment to create multiple research sites aimed at increasing health equity in clinical research

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments

IgniteData secures £1/2 million Innovate UK grant for ground-breaking clinical trial data project

IgniteData has been awarded £1/2 million from Innovate UK Smart Grants to fund a transformative clinical research data project. The initiative will focus on providing hospitals and trial sponsors with streamlined access to unstructured healthcare data, delivering efficiencies, reducing costs and improving patient care. The funding will enable IgniteData to build on existing work addressing the challenges around unstructured data (such as diagnoses, clinical procedures and free text notes) and the role of Artificial Intelligence (AI) in enhancing data accessibility for clinical studies.

SIRIO launches personalised women’s health platform at Vitafoods Europe

New ready-to-launch formulation range features premium branded ingredients, and targets issues as diverse as PMS, fertility, prenatal & postnatal care and menopause wellbeing.

CluePoints’ Site Profile & Oversight Tool (SPOT) shortlisted as finalist in 2024 Citeline Awards

CluePoints, providers of best-in-class statistical and AI-driven software solutions, has been shortlisted as finalist for the Best Sponsor-facing Technology Initiative in the 2024 Citeline Awards. CluePoints was recognized for its Site Profile & Oversight Tool (SPOT), - due to launch to the market in June 2024 – and was developed collaboratively, based on market needs, with two large pharmaceutical clients of CluePoints who helped provide direction and feedback regarding the required features and functionalities.

Phastar’s Clinical Intelligence Portal Shortlisted as Finalist in 2024 Citeline Award

Phastar, a global specialist biometrics contract research organization (CRO), has been selected as finalist for the Best Sponsor-facing Technology Initiative at the Citeline Awards 2024. Phastar were recognised for the launch of their Clinical Intelligence Portal, and notably the comprehensive recruitment forecasting app within that suite.

CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency

Alfa Chemistry Expands Offering of Polymer Fibers: Polyester Fiber, Polyamide Fiber, Aromatic Polyamide Fiber, and Polyacrylonitrile Fiber

ENPICOM secures financing from BOP Capital, BOM Brabant Ventures and brings Dr. Colby Souders on board as a new investor

Investment to bolster international partnerships and advance AI-driven solutions for antibody discovery

Alfa Chemistry’s MS and NMR Center Enables Fast, Cost-Effective Laboratory Analytical Testing

ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors

ReciBioPharm and GeneVentiv Therapeutics partner to accelerate AAV-based gene therapy for haemophilia patients

CD Formulation Incorporates Phase Separation Method for Microsphere Production

CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies

Alfa Chemistry Adds to Its Lineup of Derivatization Reagents for High-Performance Liquid Chromatography (HPLC)

Dr. Vince Clinical Research Announces First Dosing in a Phase II Study in Patients With Depression

Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology

Don't Miss: Huateng Pharma's Exhibit at CPHI Japan 2024

Hunan Huateng Pharmaceutical Co., Ltd is set to present its groundbreaking solutions at CPHI Japan 2024, showcasing expertise in PEG derivatives and CDMO services. Attendees are encouraged to visit Booth No. 4X-08 to explore cutting-edge offerings and engage with industry experts.

Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials

Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials

Join Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024

Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.

New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day